BioPharma Credit PLC
BOPCF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 70.3% | -42.7% | 38.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 108.6% | 127% | 100% | 100% |
| EBITDA | $0 | -$0 | $0 | -$0 |
| % Margin | 0% | -158.5% | 90.8% | -0% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 94.3% | 111.1% | 90.8% | 65.6% |
| EPS Diluted | 0.063 | 0.042 | 0.058 | 0.029 |
| % Growth | 50.7% | -27.2% | 100.3% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |